Novel Therapies for Kidney Disease in People with Diabetes
CONCLUSION: Trials have yielded promising results in the search for new therapies to manage DKD. Sodium-glucose cotransporter-2 inhibitors and incretin-related therapies have demonstrated benefit and were associated with improved cardiovascular outcomes. Mineralocorticoid-receptor antagonists are another class of agents with increasing evidence of benefits.PMID:34460928 | DOI:10.1210/clinem/dgab639
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Nayana Khurana Steven James Melinda T Coughlan Richard J MacIsaac Elif I Ekinci Source Type: research
More News: Allopurinol | Atorvastatin Calcium | Cardiology | Cardiovascular | Clinical Trials | Databases & Libraries | Diabetes | Diabetes Type 1 | Doxycycline | Endocrinology | Fenofibrate | Heart | Incretin Therapy | Lipitor | Omega 3 | Sodium | Statin Therapy | Thunder God Vine | Tricor | Turmeric | Urology & Nephrology | Vitamin D | Vitamins | Zivast